Would you consider use of upfront BV plus nivolumab to treat Hodgkin Lymphoma in elderly patients unable to receive standard chemotherapy?  

Are there other regimens you employ for patients unsuitable for standard chemotherapy?



Answer from: Medical Oncologist at Academic Institution